AcquisitionOther
ImmunityBio, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
ImmunityBio, Inc. -> target
The agreement will provide ImmunityBio with a state-of-the-art biotech production facility that will substantially expand and diversify ImmunityBios existing manufacturing capacity in the U.S., South Africa, and Botswana through its strategic collaborators.
Open source record (SEC) ↗